Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Virtus Investment Partners, Inc. (VRTS)
NYSEFinancialsAsset ManagementSnapshot 2026-11-04
$128.89+7.02%
Close 2026-11-04 · 1-day change
NYSEFinancialsAsset ManagementSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
24.12 → 21.65 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for VRTS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain dividend payments at or above $2.4 per share annually | A supporting condition in Virtus Investment Partners, Inc.'s published investment case. The stated target is >= $2.4 per share annually. | Intact | dividend per share falls below $2.4 annually in FY26 | Dividend per share: $2.40 per share FY2026-Q2; GAAP. Published target: >= $2.4 per share annually. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 20262.4 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a financial-sector asset manager with a mixed, execution-sensitive multi-year view, rather than a clear durable compounder or turnaround. The thesis state is watch: recent signals improved from mixed to mildly favorable, but recent financial performance remains weak and earnings quality fragile.
VRTS is described as cheap versus peers, though the valuation model has low confidence. The expectations gap is negative, while the priced-in assessment says the current fragility is justified and not unusually concentrated.
Near term, consecutive earnings misses and a 41% estimated miss probability make the next report an important test. Assets under management recovered from $149.0 billion in the first quarter to $152.2 billion in the second, with positive flows in ETFs and wealth management, while integration of Keystone remains in progress with limited detail on realized benefits. Dividend payments and share repurchases have been consistent, but that does not resolve the weak recent performance.
The multi-year thesis depends on whether VRTS can sustain asset growth and improve execution while integrating Keystone. A guidance cut or lower interest rates would be unfavorable under the snapshot's scenarios, while continued strong results and higher guidance from sector peers could support the sector backdrop.
Over the next 1 to 3 years, the long-term thesis rests on improving earnings execution and turning recent asset-flow gains into durable progress; evidence so far is mixed. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Enhance net income from $6.15M in Q1 2026 | The company aims to improve operating and net income despite recent declines. | Broken | net income remains below $6M quarterly average in FY26 | Net income: $44.607M FY2026-Q2; GAAP. Published target: > $20M quarterly run-rate by end of FY26. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 202644,607,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating income from $15.45M in Q1 2026 | The company aims to improve operating and net income despite recent declines. | Under Pressure | operating income fails to rise above $15M quarterly average in FY26 | Operating income: $27.324M FY2026-Q2; GAAP. Published target: > $30M quarterly run-rate by end of FY26. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 202627,324,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Limit revenue decline to less than -7% YoY | A primary condition in Virtus Investment Partners, Inc.'s published investment case. The stated target is revenue decline > -7% YoY. | Broken | revenue decline exceeds -7% YoY in FY26 | Revenue growth: -4.35% FY2026-Q2; GAAP. Published target: revenue decline > -7% YoY. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 2026-4.352452 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$25.51 → $21.65 · observed estimates
$0.75B → $0.68B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $25.51 | $752,513,630 | 3 / 2 |
| 2026-07-25 | $25.50 | $755,026,630 | 4 / 2 |
| 2026-07-26 | $25.50 | $755,026,630 | 4 / 2 |
| 2026-07-27 | $25.50 | $755,026,630 | 4 / 2 |
| 2026-07-28 | $25.50 | $755,026,630 | 4 / 2 |
| 2026-07-29 | $25.34 | $749,553,801 | 3 / 2 |
| 2026-07-30 | $25.50 | $755,026,630 | 4 / 2 |
| 2026-07-31 | $24.99 | $748,063,300 | 4 / 2 |
| 2026-08-01 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-02 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-03 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-04 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-05 | $24.56 | $748,063,300 | 4 / 2 |
| 2026-08-06 | $24.56 | $748,063,300 | 4 / 2 |
| 2026-08-08 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-09 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-10 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-12 | $24.56 | $748,063,300 | 4 / 2 |
| 2026-08-13 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-14 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-15 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-16 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-17 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-18 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-19 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-20 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-21 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-22 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-23 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-24 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-25 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-26 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-27 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-28 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-29 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-30 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-08-31 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-01 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-02 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-03 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-04 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-05 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-06 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-07 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-08 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-09 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-10 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-11 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-12 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-13 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-14 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-15 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-16 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-17 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-18 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-19 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-20 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-21 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-22 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-23 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-24 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-25 | $24.56 | $748,063,301 | 3 / 2 |
| 2026-09-26 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-09-27 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-09-28 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-09-29 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-09-30 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-01 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-02 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-03 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-04 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-05 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-06 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-07 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-08 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-09 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-10 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-11 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-12 | $24.12 | $726,928,072 | 3 / 2 |
| 2026-10-13 | $23.71 | $726,928,072 | 3 / 2 |
| 2026-10-14 | $23.71 | $726,928,072 | 3 / 2 |
| 2026-10-15 | $22.89 | $726,928,072 | 3 / 2 |
| 2026-10-16 | $22.89 | $726,928,072 | 3 / 2 |
| 2026-10-17 | $22.89 | $726,928,072 | 3 / 2 |
| 2026-10-18 | $22.89 | $726,928,072 | 3 / 2 |
| 2026-10-19 | $22.89 | $726,928,072 | 3 / 2 |
| 2026-10-20 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-21 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-22 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-23 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-24 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-25 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-26 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-27 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-28 | $22.12 | $693,724,572 | 3 / 2 |
| 2026-10-29 | $21.65 | $678,133,562 | 3 / 2 |
| 2026-10-30 | $21.65 | $678,133,562 | 3 / 2 |
| 2026-10-31 | $21.65 | $678,133,562 | 3 / 2 |
| 2026-11-01 | $21.65 | $678,133,562 | 3 / 2 |
| 2026-11-02 | $21.65 | $678,133,562 | 3 / 2 |
| 2026-11-03 | $21.65 | $678,133,562 | 3 / 2 |
| 2026-11-04 | $21.65 | $678,133,562 | 3 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 1 Hold · 2 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.